FLT3 and acute myeloid leukemia: This growth factor has also been identified as a mediator of resistance to FLT3 inhibition, as evidenced by, for example, a study presented by Sato et al., which notes elevated levels of FLT3 ligand in patients who had relapsed compared to patients who had just been diagnosed with AML [102].